{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:51:59Z","timestamp":1791474719883,"version":"4.3.4"},"reference-count":23,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Otolaryngol Head Neck Surg"],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Imaging-detected extranodal extension (iENE) has been included in the American Joint Committee on Cancer (AJCC) and Union for International Cancer Control (UICC) protocol tumor-node-metastasis 9th edition staging system (TNM9) for human papillomavirus (HPV)-mediated (p16-positive) oropharyngeal cancer (HPV-positive OPC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To confirm the new TNM9 staging system on a prospective dataset.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This prognostic study included patients with HPV-positive OPC with clinically node-positive disease treated at 182 health care centers in the US and Canada and enrolled in the NRG Radiation Therapy Oncology Group (RTOG) 1016 trial between 2011 and 2014 were included. Deidentified images were reviewed between September and December 2021. Data were analyzed between May and September 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Exposure<\/jats:title>\n                    <jats:p>Computed tomography simulation scans were reviewed by 2 expert head and neck radiologists documenting the presence of iENE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Kaplan-Meier analysis was used to estimate overall survival (OS) and progression-free survival (PFS). Cumulative incidence curves were generated for locoregional failure (LRF) and distant metastasis. Univariate (UVA) and multivariate analyses (MVA) were performed incorporating iENE with other known prognostic factors. The TNM9 clinical nodal schema incorporating iENE was compared with the previous TNM8. Model goodness of fit and comparison of models was done using Akaike information criterion (AIC) and Harrell concordance statistic (C index).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 987 patients enrolled in NRG RTOG 1016, 586 met inclusion criteria (median age, 58 years [range, 33-83 years]; 534 male [91.1%]), 350 (60%) of whom had iENE. Median (IQR) follow-up was 4.2 (3.3-5.0) years. Patients with iENE had inferior 5-year OS (79.2% vs 87.0%; difference, 7.8% [95% CI, 1.2%-14.4%]) and 5-year PFS (68.8% vs 80.4%; difference, 11.6% [95% CI, 4.1%-19.2%]) compared with those without iENE. On MVA, iENE was independently associated with inferior OS (HR, 1.63; 95% CI, 1.04-2.56) and PFS (HR, 1.78; 95% CI, 1.24-2.57). TNM9 and TNM8 clinical nodal schemas had similar performance in terms of C index and AIC (TNM8: C, 0.73 [95% CI, 0.68-0.78]; AIC\u2009=\u20091109.34 vs TNM9: C, 0.72 [95% CI, 0.67-0.77]; AIC\u2009=\u20091112.70).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>This study showed that the updated TNM9 clinical nodal schema, in which patients with iENE-positive disease are upstaged 1 stratum from their TNM8 clinical N category, discriminates better than the TNM8 category between patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov Identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/study\/NCT01302834\">NCT01302834<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamaoto.2026.0932","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:30:38Z","timestamp":1787844638000},"page":"981","source":"Crossref","is-referenced-by-count":0,"title":["Imaging-Detected Extranodal Extension in p16-Positive Oropharyngeal Cancer"],"prefix":"10.1001","volume":"152","author":[{"given":"Christopher W.","family":"Fleming","sequence":"first","affiliation":[{"name":"Maroone Cancer Center, Cleveland Clinic Florida, Weston, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandana A.","family":"Reddy","sequence":"additional","affiliation":[{"name":"Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Stock","sequence":"additional","affiliation":[{"name":"Diagnostic Institute, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Lee","sequence":"additional","affiliation":[{"name":"Diagnostic Institute, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Gillison","sequence":"additional","affiliation":[{"name":"MD Anderson Cancer Center, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy J.","family":"Caudell","sequence":"additional","affiliation":[{"name":"Moffitt Cancer Center, Tampa, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica L.","family":"Geiger","sequence":"additional","affiliation":[{"name":"Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dukagjin M.","family":"Blakaj","sequence":"additional","affiliation":[{"name":"The Ohio State University Arthur James Cancer Center, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg A.","family":"Krempl","sequence":"additional","affiliation":[{"name":"University of Oklahoma Health Sciences Center, Oklahoma City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Dimitrios","family":"Colevas","sequence":"additional","affiliation":[{"name":"Stanford University, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher U.","family":"Jones","sequence":"additional","affiliation":[{"name":"Sutter Cancer Research Consortium, Roseville, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil F.","family":"Saba","sequence":"additional","affiliation":[{"name":"Winship Cancer Institute, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Phan","sequence":"additional","affiliation":[{"name":"MD Anderson Cancer Center, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Galloway","sequence":"additional","affiliation":[{"name":"Fox Chase Cancer Center, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Seaward","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Northern California, Vallejo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Spencer","sequence":"additional","affiliation":[{"name":"University of Alabama at Birmingham Cancer Center, Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Torres-Saavedra","sequence":"additional","affiliation":[{"name":"Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland"},{"name":"NRG Oncology, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue S.","family":"Yom","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quynh-Thu","family":"Le","sequence":"additional","affiliation":[{"name":"Stanford University, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shlomo A.","family":"Koyfman","sequence":"additional","affiliation":[{"name":"Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"Suppl 1","key":"ooi260022r1","doi-asserted-by":"publisher","first-page":"E1192","DOI":"10.1002\/hed.24190","article-title":"Influence of extracapsular nodal spread extent on prognosis of oral squamous cell carcinoma.","volume":"38","author":"Wreesmann","year":"2016","journal-title":"Head Neck"},{"issue":"6","key":"ooi260022r2","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1002\/hed.21244","article-title":"Extracapsular spread in oral squamous cell carcinoma.","volume":"32","author":"Shaw","year":"2010","journal-title":"Head Neck"},{"issue":"10","key":"ooi260022r3","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1002\/hed.20279","article-title":"Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501).","volume":"27","author":"Bernier","year":"2005","journal-title":"Head Neck"},{"issue":"6","key":"ooi260022r4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s11912-019-0799-x","article-title":"Changes in the 8th Edition of the American Joint Committee on Cancer (AJCC) Staging of Head and Neck Cancer: rationale and implications.","volume":"21","author":"Zanoni","year":"2019","journal-title":"Curr Oncol Rep"},{"issue":"7","key":"ooi260022r5","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1001\/jamaoto.2016.0882","article-title":"Association of extracapsular spread with survival according to human papillomavirus status in oropharynx squamous cell carcinoma and carcinoma of unknown primary site.","volume":"142","author":"Kharytaniuk","year":"2016","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"10","key":"ooi260022r6","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1002\/lary.30572","article-title":"Extranodal extension improves AJCC-8 accuracy in HPV+ oropharyngeal cancer in a high-risk population.","volume":"133","author":"Burruss","year":"2023","journal-title":"Laryngoscope"},{"issue":"4","key":"ooi260022r7","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1177\/0194599820951176","article-title":"Prognostic significance of extranodal extension in hpv-mediated oropharyngeal carcinoma: a systematic review and meta-analysis.","volume":"164","author":"Benchetrit","year":"2021","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"1","key":"ooi260022r8","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/oncolo\/oyab001","article-title":"Comparison of the Seventh and Eighth Edition of American Joint Committee on Cancer (AJCC) Staging for Selected and Nonselected Oropharyngeal Squamous Cell Carcinomas.","volume":"27","author":"Vijayvargiya","year":"2022","journal-title":"Oncologist"},{"issue":"4","key":"ooi260022r9","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/S1470-2045(15)00560-4","article-title":"Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study.","volume":"17","author":"O\u2019Sullivan","year":"2016","journal-title":"Lancet Oncol"},{"issue":"5","key":"ooi260022r10","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.ijrobp.2019.03.047","article-title":"Radiologic extranodal extension portends worse outcome in cN+ TNM-8 Stage I human papillomavirus-mediated oropharyngeal cancer.","volume":"104","author":"Billfalk-Kelly","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ooi260022r11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.radonc.2019.10.011","article-title":"Prognostic importance of radiologic extranodal extension in HPV-positive oropharyngeal carcinoma and its potential role in refining TNM-8 cN-classification.","volume":"144","author":"Huang","year":"2020","journal-title":"Radiother Oncol"},{"issue":"7","key":"ooi260022r12","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1001\/jamaoto.2025.0848","article-title":"A proposal for HPV-associated oropharyngeal carcinoma in the Ninth Edition Clinical TNM Classification.","volume":"151","author":"Huang","year":"2025","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"10166","key":"ooi260022r13","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S0140-6736(18)32779-X","article-title":"Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial.","volume":"393","author":"Gillison","year":"2019","journal-title":"Lancet"},{"issue":"6","key":"ooi260022r14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamaoncol.2022.0615","article-title":"Assessment of toxic effects and survival in treatment deescalation with radiotherapy vs transoral surgery for HPV-associated oropharyngeal squamous cell carcinoma: the ORATOR2 Phase 2 Randomized Clinical Trial.","volume":"8","author":"Palma","year":"2022","journal-title":"JAMA Oncol"},{"key":"ooi260022r15","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2022.105716","article-title":"Inter-rater concordance and operating definitions of radiologic nodal feature assessment in human papillomavirus-positive oropharyngeal carcinoma.","volume":"125","author":"Chin","year":"2022","journal-title":"Oral Oncol"},{"issue":"11","key":"ooi260022r16","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1002\/hed.27130","article-title":"Augmenting inter-rater concordance of radiologic extranodal extension in HPV-positive oropharyngeal carcinoma: a multicenter study.","volume":"44","author":"Hoebers","year":"2022","journal-title":"Head Neck"},{"issue":"2","key":"ooi260022r17","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1200\/JCO.21.01752","article-title":"Phase II randomized trial of transoral surgery and low-dose intensity modulated radiation therapy in resectable p16+ locally advanced oropharynx cancer: an ECOG-ACRIN Cancer Research Group Trial (E3311).","volume":"40","author":"Ferris","year":"2022","journal-title":"J Clin Oncol"},{"issue":"9","key":"ooi260022r18","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1200\/JCO.20.03128","article-title":"Reduced-dose radiation therapy for HPV-associated oropharyngeal carcinoma (NRG Oncology HN002).","volume":"39","author":"Yom","year":"2021","journal-title":"J Clin Oncol"},{"issue":"7","key":"ooi260022r19","doi-asserted-by":"publisher","first-page":"e297","DOI":"10.1016\/S1470-2045(24)00066-4","article-title":"Criteria for the diagnosis of extranodal extension detected on radiological imaging in head and neck cancer: Head and Neck Cancer International Group consensus recommendations.","volume":"25","author":"Henson","year":"2024","journal-title":"Lancet Oncol"},{"issue":"3","key":"ooi260022r20","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1177\/1971400917694048","article-title":"Computed tomography detection of extracapsular spread of squamous cell carcinoma of the head and neck in metastatic cervical lymph nodes.","volume":"30","author":"Carlton","year":"2017","journal-title":"Neuroradiol J"},{"issue":"1","key":"ooi260022r21","doi-asserted-by":"publisher","first-page":"77.e23","DOI":"10.1016\/j.crad.2019.09.138","article-title":"Accuracy of contrast-enhanced CT and predictive factors for extracapsular spread in unknown primary head and neck squamous cell cancer.","volume":"75","author":"Douglas","year":"2020","journal-title":"Clin Radiol"},{"issue":"7","key":"ooi260022r22","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1017\/S0022215109004332","article-title":"Sensitivity and specificity of computed tomography for detection of extranodal spread from metastatic head and neck squamous cell carcinoma.","volume":"123","author":"Souter","year":"2009","journal-title":"J Laryngol Otol"},{"issue":"5","key":"ooi260022r23","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1200\/JCO-24-02679","article-title":"Automated lymph node and extranodal extension assessment improves risk stratification in oropharyngeal carcinoma.","volume":"44","author":"Ye","year":"2026","journal-title":"J Clin Oncol"}],"container-title":["JAMA Otolaryngology\u2013Head &amp; Neck Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaotolaryngology\/articlepdf\/2853091\/jamaotolaryngology_fleming_2026_oi_260022_1791389938.97201.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:00:44Z","timestamp":1791471644000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaotolaryngology\/fullarticle\/2853091"}},"subtitle":["Secondary Analysis of RTOG 1016"],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":23,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoto.2026.0932","relation":{},"ISSN":["2168-6181"],"issn-type":[{"value":"2168-6181","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,1]]}}}